Medical Radiation Detection Market Size, Share, and Trends

Medical Radiation Detection Market (By Type: Gas-Filled Detectors, Scintilators, Solid-State; By Product: Personal Dosimeters, Area Process Dosimeters, Surface Contamination Monitors, Others; By End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : July 2024
  • Report Code : 3389
  • Category : Healthcare

The global medical radiation detection market size was USD 1.02 billion in 2023, calculated at USD 1.10 billion in 2024, and is expected to reach around USD 2.25 billion by 2034, expanding at a CAGR of 7.4% from 2024 to 2034. 

Medical Radiation Detection Market Size 2024 To 2034

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Medical Radiation Detection Market Key Takeaways

  • North America led the global market with the highest market share of 35% in 2023.
  • Asia-Pacific is predicted to expand at the fastest CAGR during the forecast period.
  • By Type, the gas-filled detectors segment has held the largest market share of 43% in 2023.
  • By Type, the solid-state detectors segment is anticipated to grow at a remarkable CAGR of 8.7% during the projected period.
  • By Product, the personal dosimeters segment had the biggest market share of 39% in 2023.
  • By Product, the surface contamination monitors segment is estimated to expand at the fastest AGR over the projected period.
  • By End-use, the hospitals segment contributed more than 44% of revenue share in 2023.
  • By End-use, the diagnostic imaging centers segment is expected to grow at a noteworthy CAGR of 7.9% over the predicted period.

Market Overview

The sphere of medical radiation detection market pertains to the global arena dedicated to crafting, fabricating, and disseminating intricate contrivances and apparatuses tailored for the discernment and quantification of ionizing radiation within medical milieus. These technological innovations play an indispensable role in safeguarding the well-being of patients and healthcare practitioners during diagnostic and therapeutic procedures that involve the utilization of X-rays, gamma rays, and other radiation modalities.

The medical radiation detection market encompasses an array of products, encompassing dosimeters, Geiger-Muller counters, scintillation detectors, and imaging systems. It thrives on factors such as mounting exposure to medical radiation, adherence to regulatory directives, and the imperative for meticulous radiation surveillance within healthcare facilities.

U.S. Medical Radiation Detection Market Size and Growth 2023-2032

The U.S. medical radiation detection market size was valued at USD 250 million in 2023 and is estimated to reach around USD 560 million by 2034, growing at a CAGR of 7.6% from 2024 to 2034.

U.S. Medical Radiation Detection Market Size 2024 To 2034

North America has held the largest revenue share 35% in 2023. North America commands a significant share due to advanced healthcare infrastructure, robust research and development activities, and stringent regulatory compliance. The region houses leading medical institutions and facilities that heavily rely on radiation technologies for diagnosis and treatment. Additionally, a growing awareness of radiation safety and a high prevalence of cancer cases drive the demand for cutting-edge radiation detection solutions. The presence of key market players and a favorable reimbursement environment further solidify North America's dominant position in the global medical radiation detection market.

Medical Radiation Detection Market Share, By Region, 2023 (%)

Asia-Pacific is estimated to observe the fastest expansion. Asia-Pacific holds a substantial growth due to several key factors. The region's population is vast, and with increasing healthcare infrastructure and diagnostic facilities, there's a growing need for radiation detection equipment in medical settings. Additionally, rising awareness about radiation safety, a surge in cancer cases demanding radiation therapy, and government initiatives for nuclear safety contribute to the market's prominence. Furthermore, technological advancements and collaborations with global players in the Asia-Pacific region further boost its market growth in the medical radiation detection sector.

Medical Radiation Detection Market Growth Factors

The realm of medical radiation detection market, an integral facet of the healthcare sector, revolves around the evolution and dispersion of advanced technologies tailored for the identification and quantification of ionizing radiation within medical environments. These pivotal instruments serve as sentinels, ensuring the security of patients and healthcare practitioners during procedures that entail the use of X-rays, gamma rays, and other sources of radiation. This market encompasses a wide array of products, including dosimeters, Geiger-Muller counters, scintillation detectors, and state-of-the-art imaging systems.

The medical radiation detection market is experiencing significant growth driven by several key trends and factors. One major trend is the increasing adoption of digital radiation detection technologies, which offer higher precision and real-time data monitoring. The rising demand for radiation therapy in cancer treatment is also fueling market growth, as healthcare facilities require advanced radiation detection solutions for accurate dosage delivery. Moreover, stringent regulatory standards and guidelines pertaining to radiation safety are encouraging healthcare institutions to invest in innovative detection and monitoring equipment. This trend is especially notable in developed regions.

Despite its promising prospects, the market is not without its challenges. One central hurdle is the substantial cost associated with cutting-edge radiation detection equipment, potentially impeding adoption among smaller healthcare facilities. Moreover, the perpetual necessity for calibration and maintenance of radiation detectors poses logistical and financial obstacles for healthcare providers. Striking a balance between cost-effective solutions and cutting-edge technology remains an ongoing conundrum for industry stakeholders.

The medical radiation detection market presents numerous opportunities for both established companies and newcomers. The increasing awareness of radiation safety among healthcare professionals and the general public opens doors for businesses offering training and education services related to radiation detection and protection. Furthermore, the emergence of compact and portable radiation detection devices provides opportunities for market expansion into outpatient and remote healthcare settings. Collaborations with research institutions to develop cutting-edge radiation detection technologies and solutions also offer substantial growth prospects.

In summary, the medical radiation detection market is driven by the adoption of digital technologies, the growing demand for radiation therapy, and regulatory compliance. However, it faces challenges related to cost and maintenance. The industry's future lies in embracing opportunities such as radiation safety education and the development of portable detection devices, making it a dynamic and evolving sector within the broader healthcare landscape.

Market Scope

Report Coverage Details
Market Size by 2032 USD 2.25 Billion
Market Size in 2023 USD 1.02 Billion
Market Size in 2023 USD 1.10 Billion
Growth Rate from 2024 to 2034 CAGR of 7.4%
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered Type, Product, End Use, and Region
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Market Dynamics

Driver

Rising incidence of cancer

The surge in cancer prevalence stands as a primary impetus behind the expansion of the medical radiation detection market. With cancer rates on an upward trajectory globally, there exists a mounting need for radiation detection technologies capable of precisely gauging and overseeing radiation dosing during treatment. This requirement arises from the necessity to tailor treatments to individual patients, striving for optimal therapeutic outcomes while mitigating the impact on healthy tissues.

Furthermore, the ongoing evolution of radiation detection equipment is ushering in more streamlined and secure treatment protocols. Advanced technologies offer real-time monitoring and feedback mechanisms, affording healthcare providers the ability to fine-tune treatment parameters when required. This not only elevates the caliber of patient care but also heightens patient comfort and nurtures confidence in the effectiveness of their treatment strategies.

In essence, the burgeoning incidence of cancer acts as a compelling force in propelling the medical radiation detection market, compelling the development of ever more intricate and precise radiation detection solutions to meet the exacting demands of contemporary oncological therapies.

Restraints

Complex regulatory environment

The intricacies of the regulatory framework present a formidable obstacle to the expansion of the medical radiation detection industry. This intricate landscape is characterized by a multitude of national and international standards, guidelines, and compliance prerequisites governing the utilization of radiation in healthcare contexts. Healthcare institutions and manufacturers of radiation detection equipment are compelled to allocate significant investments in terms of both time and resources to ensure alignment with these intricate regulations. Maintaining compliance necessitates ongoing effort, which can hamper the pace of product development and market entry.

Furthermore, the dynamic nature of regulatory requirements demands continuous adaptation and adjustments to equipment and procedures, amplifying the costs and complexities associated with compliance. Such intricacies may dissuade smaller entrants from participating in the market and challenge their ability to effectively compete. The elaborate regulatory landscape can also lead to protracted product approval and market clearance processes, impinging upon the timely introduction of innovative radiation detection technologies. In sum, the complex regulatory milieu erects formidable barriers that hinder market growth and innovation within the medical radiation detection sector.

Opportunities

Expansion of radiation therapy 

The burgeoning utilization of radiation therapy, encompassing both its application in cancer treatment and its emerging role in addressing non-cancerous conditions, is cultivating noteworthy prospects within the medical radiation detection industry. With healthcare institutions increasingly relying on radiation therapy to elevate patient outcomes, a burgeoning demand arises for cutting-edge radiation detection technologies that can ensure the precision and safety of radiation delivery. This demand extends to the development of equipment capable of real-time radiation dosage monitoring and adjustment, thereby augmenting treatment precision and diminishing potential side effects.

Opportunities unfurl in the realm of pioneering radiation detection devices tailored explicitly to the unique requisites of radiation therapy. These technologies should not only meet exacting regulatory mandates but also encompass attributes such as heightened sensitivity, seamless data integration, and intuitive user interfaces. Additionally, offering comprehensive training and support services to healthcare practitioners utilizing these advanced tools constitutes another avenue for expansion. In essence, the expanding domain of radiation therapy provides a fertile ground for market participants to innovate, fostering enhanced patient care while fortifying their presence within the sphere of medical radiation detection.

Type Insights

The gas-filled detectors sector has held a 43% revenue share in 2023. The gas-filled detectors segment holds a significant share due to its reliability, accuracy, and wide range of applications. Gas-filled detectors, like ionization chambers and proportional counters, are well-established and trusted technologies for measuring ionizing radiation. They offer precise dose measurements, making them essential in radiation therapy for cancer treatment. Additionally, they are often used in diagnostic radiology, nuclear medicine, and laboratory research. Their versatility and proven performance have solidified their position, making them a preferred choice for healthcare facilities, and contributing to the segment's substantial market share.

The solid-state detectors are anticipated to expand at a significant CAGR of 8.7% during the projected period. The solid-state detectors segment commands substantial growth in the medical radiation detection market due to several key advantages. Solid-state detectors offer superior accuracy and sensitivity in measuring ionizing radiation, making them crucial for precise radiation therapy and diagnostic procedures. They are more durable, require less maintenance, and have a longer lifespan compared to traditional detectors. Additionally, their compact size and ability to provide real-time data make them ideal for modern healthcare settings. As the industry increasingly emphasizes precision and efficiency in radiation detection, solid-state detectors have become the preferred choice, contributing to their major market growth.

Product Insights

The personal dosimeters sector had the highest market share of 39% on the basis of the product in 2023. The personal dosimeters segment commands a significant share due to its critical role in safeguarding the well-being of healthcare workers and radiation professionals. Personal dosimeters are worn by individuals exposed to ionizing radiation, providing real-time monitoring of their radiation exposure levels. With increasing awareness of radiation safety, stringent regulatory requirements, and a growing number of diagnostic and therapeutic procedures involving radiation, the demand for personal dosimeters has surged. This segment's prominence reflects the industry's commitment to ensuring the safety of personnel and compliance with radiation protection standards, thereby contributing to its substantial market share.

The surface contamination monitors is anticipated to expand at the fastest rate over the projected period. The surface contamination monitors segment holds a significant growth due to its critical role in ensuring radiation safety. These monitors are essential for detecting and quantifying radioactive materials on surfaces, equipment, and personnel, preventing contamination spread and minimizing radiation exposure. With stringent regulatory requirements and increased awareness of radiation safety, healthcare facilities and nuclear power plants rely heavily on surface contamination monitors to maintain compliance. Moreover, ongoing technological advancements have made these monitors more efficient and user-friendly, further driving their adoption and market growth within the broader field of radiation detection.

End-use Insights

The hospitals segment held the largest revenue share of 44% in 2023. Hospitals hold a major share due to their central role in healthcare delivery. Hospitals are primary locations for diagnostic imaging, radiation therapy, and interventional procedures, all of which involve ionizing radiation. To ensure patient safety and regulatory compliance, hospitals invest significantly in radiation detection equipment. Additionally, the rising incidence of cancer and the increasing demand for radiation therapy contribute to the dominance of hospitals in the market. Their access to resources, expertise, and the need for comprehensive radiation detection solutions make hospitals a key driver of market growth and innovation.

Medical Radiation Detection Market Share, By End Use, 2023 (%)

The diagnostic imaging centers segment is anticipated to grow at a significantly faster rate, registering a CAGR of 7.9% over the predicted period. The diagnostic imaging centers segment holds a substantial growth due to several factors. These centers are vital hubs for various medical imaging procedures, including X-rays, CT scans, and MRIs, all of which involve ionizing radiation. Ensuring accurate dosage delivery and radiation safety is paramount, driving the demand for sophisticated detection technologies. Additionally, diagnostic imaging centers often handle a high volume of patients, necessitating efficient and reliable radiation detection systems. Stringent regulatory standards further emphasize the need for precise monitoring, making this segment a significant contributor to the market's growth and revenue.

Medical Radiation Detection Market Companies

  • Thermo Fisher Scientific, Inc.
  • UAB Polimaster Europe
  • PTW Freiburg GmbH
  • ATOMTEX
  • Sanlar imex services private limited
  • LANDAUER
  • Mirion Technologies, Inc
  •  MP BIOMEDICALS. 
  • SIERRA RADIATION DOSIMETRY SERVICE, INC.
  • IBA Dosimetry GmbH

Recent Developments

  • In March 2021, Infab, LLC (USA) introduced its innovative product, the 903 Reverse Vest & Skirt, designed to offer robust protection against scatter radiation while ensuring a secure and comfortable fit for users.
  • In October 2021, Mirion Technologies, Inc. (USA) expanded its global presence through the acquisition of Sun Nuclear Corporation, a company with a footprint in more than 100 countries. This strategic acquisition was aimed at bolstering Mirion's market position. In January 2021, Infab, LLC (USA) broadened its portfolio by acquiring MediDrapes, a provider of disposable protective drapes utilized in medical imaging equipment like mini C-arms, fluoroscopes, and ultrasound machines.
  • In June 2021, Mirion Technologies Inc. achieved a significant milestone by becoming a publicly-traded company following a business merger with GS Acquisition Holdings Corp II, a special purpose acquisition company backed by an affiliate of The Goldman Sachs Group. This transaction was supported by a private investment in public equity (PIPE) of USD 900 million from notable investors, including Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds, and Janus Henderson Investors.
  • In May 2021, radiation monitoring systems were inaugurated at Queen Alia and Amman Civil airports in Jordan. This project received funding from the Canadian government as part of a bilateral agreement aimed at enhancing Jordan's nuclear security infrastructure. The initiative had a budget of CAD 4.5 million, contributing to a broader CAD 30 million agreement between the two governments dedicated to strengthening Jordan's capabilities in the field of nuclear security.

Segments Covered in the Report

By Type

  • Gas-Filled Detectors
  • Scintilators
  • Solid-State

By Product

  • Personal Dosimeters
  • Area Process Dosimeters
  • Surface Contamination Monitors
  • Others

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global medical radiation detection market size was exhibited at USD 1.02 billion in 2023 and is expected to increase USD 2.25 billion by 2034.

The global medical radiation detection market will register growth rate of 7.4% between 2024 and 2034.

The major players operating in the medical radiation detection market are Thermo Fisher Scientific, Inc., UAB Polimaster Europe, PTW Freiburg GmbH, ATOMTEX, Sanlar imex services private limited, LANDAUER, Mirion Technologies, Inc, MP BIOMEDICALS., SIERRA RADIATION DOSIMETRY SERVICE, INC., IBA Dosimetry GmbH, and Others.

The driving factors of the medical radiation detection market are the rising demand for radiation therapy in cancer treatment and increasing adoption of digital radiation detection technologies.

North America region will lead the global medical radiation detection market during the forecast period 2024 to 2034.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Radiation Detection Market 

5.1. COVID-19 Landscape: Medical Radiation Detection Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Radiation Detection Market, By Type

8.1. Medical Radiation Detection Market, by Type, 2024-2034

8.1.1 Gas-Filled Detectors

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Scintilators

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Solid-State

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Medical Radiation Detection Market, By Product

9.1. Medical Radiation Detection Market, by Product, 2024-2034

9.1.1. Personal Dosimeters

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Area Process Dosimeters

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Surface Contamination Monitors

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Medical Radiation Detection Market, By End Use 

10.1. Medical Radiation Detection Market, by End Use, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Diagnostic Imaging Centers

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Medical Radiation Detection Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. UAB Polimaster Europe

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. PTW Freiburg GmbH

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. ATOMTEX

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Sanlar imex services private limited

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. LANDAUER

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Mirion Technologies, Inc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. MP BIOMEDICALS.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. SIERRA RADIATION DOSIMETRY SERVICE, INC.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. IBA Dosimetry GmbH

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

 

14.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client